Replies to post #149517 on Biotech Values

[poorgradstudent]

ONXX / Regorafenib:

Most anticlimactic approval ever. Seems the market hasn't even noticed.

[jq1234]

ONXX/Bayer Stivarga

Here is press release. Per BioWorld, ONXX excercised co-promotion rights.


http://finance.yahoo.com/news/bayers-stivarga-regorafenib-tablets-approved-165700629.html